Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (16/01/2025) announced the following initial list of price concessions for January 2025: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £3.80 Calcipotriol 0.005% / Betamethasone dipropionate 0.05%
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Xylocaine® (lidocaine) 10mg spray MSN/2025/003 Tier 2 medium impact Date of issue: 14th January 2025 Xylocaine® (lidocaine) 10mg spray is out of stock until mid-February 2025. Lidocaine 5% / Phenylephrine 0.5% spray remains available and can support an increase in demand.
Read moreMHRA Class 4 Medicines Defect Notification: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV) Drug alert number: EL(25)A/02 Date issued: 13 January 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV)
Read morePharmacy owners who submit their FP34C declaration through the Manage Your Service (MYS) portal by the 5th of the month (or by the 6th if one or more bank holiday occurs during the first five days of the month) will receive 100% of their advance payments four working days after the submission deadline. The table below
Read more“Pharmacy businesses need a clear pathway to a better future which they can both have confidence in and plan for,” says Community Pharmacy England Chief Executive Janet Morrison in a new blog. Community pharmacy owners are “exasperated and desperate” and the sector needs answers on a range of key issues. In her latest blog, Janet
Read moreBy Chief Executive Janet Morrison New year, new you… so the mantra goes. But for community pharmacy owners the start of 2025 will feel very much like the end of the last year. Already, just ten days in, we have seen national media coverage of pharmacy owners investing their personal savings to keep their business
Read moreThe Government has today responded to the Health Select Committee’s report into the state of community pharmacy, addressing each of the report’s recommendations to support the sector. In its response, the Government has reaffirmed its ambition to expand the role of pharmacies and to improve workforce planning, but it has not set out answers to
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Apomorphine hydrochloride (APO-go® PFS) 50mg/10ml solution for infusion pre-filled syringes. MSN/2025/002 Tier 2 – medium impact Date of issue: 9th January 2025 APO-go® (apomorphine hydrochloride) PFS are being discontinued; supplies are anticipated to be exhausted from early April 2025. APO-go® POD
Read moreMHRA Class 4 Medicines Defect Notification: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets (Bristol Laboratories Limited) Drug alert number: EL (25)A/01 Date issued: 09 January 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets (Bristol Laboratories Limited) DMRC
Read moreDate issued: 8 January 2025 TriOn Pharma is recalling two food supplement products. Aactive D3 Drops and Aactive D3 Solution because they contain higher levels of vitamin D3 than written on the label. Aactive D3 2,000iu/ml Oral Drops Batch No Expiry Date Pack Size LS23317 November 2025 20ml Aactive D3 2,000iu/ml Oral Solution Batch No
Read more
